linc‑ROR facilitates hepatocellular carcinoma resistance to doxorubicin by regulating TWIST1‑mediated epithelial‑mesenchymal transition

Yuanbiao Zhang(Second Affiliated Hospital of Zhejiang University), Weilin Wang(Zhejiang University)
Molecular Medicine Reports
March 9, 2021
Cited by 21


Related Papers